This message was sent to ##Email##
Advertisement
|
|
|
|
|
TOS
The Obesity Society is pleased to announce the first-ever National Obesity Care Week (NOCW), Nov. 1-7, 2015, which seeks to ignite a national movement to ensure anyone affected by obesity receives respectful and comprehensive care.
TOS is a proud founder of the campaign alongside our partners the Obesity Action Coalition, Strategies to Overcome and Prevent Obesity Alliance and the American Society for Metabolic and Bariatric Surgery. More than 30 like-minded organizations are also joining the Campaign from across the healthcare industry including the American Association of Clinical Endocrinology, The Endocrine Society and the Obesity Medicine Association.
All supporters recognize that obesity is a multifactorial disease that can only be addressed with the full spectrum of evidence-based medical strategies. These strategies include:
- Intensive behavioral treatment
- Behavior modification: exercise, diet/meal replacement, support groups
- Weight management products and programs
- Physician-supervised weight management
- Medications for weight loss and chronic weight management
- Bariatric surgery
This year, the Campaign targets healthcare professionals, encouraging them to use the Campaign's trusted medical tools and resources available online to facilitate more active engagement with patients living with obesity.
Our rallied efforts officially kick off at ObesityWeek℠ 2015, the premier, international conference focused on the science and treatment of obesity.
We need more voices — your voice — to reach our goal of achieving better care. Take the Treat Obesity Seriously Pledge and find out more about how to sign on as a supporter. Mark your calendars, and join us in recognizing National Obesity Care Week, Nov. 1–7.
Advertisement
| ObesityWeek is fast approaching! Here are a few reminders...
|
    |
TOS
With The Obesity Society Annual Meeting at ObesityWeek just a few weeks away, we wanted to pass along the following reminders to help you plan:
- Advance registration closes on Oct. 30. Be sure to register online before that date to avoid lines and increased pricing on site.
- Program books and abstract books are available for pre-order when you register. We will have a limited quantity for sale on-site.
- Poster printing deadlines are approaching. If you need your poster printed, make sure to connect with Call4Posters™ before the Oct. 23 deadline.
- We're excited to bring back the ObesityWeek meeting app so you can navigate the meeting schedule directly from your smartphone or tablet. Keep an eye out for announcements!
TOS
Beginning in 2015 and awarded annually at ObesityWeek, TOS is pleased to announce the establishment of two new awards for our student members.
1) George Bray, MD, Master's Thesis Award
2) George Bray, MD, Doctoral Dissertation Award
Each recipient receives $1500 for ObesityWeek travel and registration plus a $500 cash award.
These awards were created to honor two students for their complete master's thesis or doctoral dissertation (respectively) that was successfully defended in the current year (between May 1, 2014 and April 30, 2015). Applications will be judged by a committee of three appointed TOS members based on: significance, relevance/potential impact in the field of obesity, scientific methodology, writing quality, overall approach and scope and innovation.
The winners will be announced/awarded at ObesityWeek during the George Bray Founders Award Lecture. Find out more here and submit your application before the Oct. 15, 2015 deadline.
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
Contributed by ABOM
Would you like to help shape the future of obesity medicine? Are you interested in raising the bar for all physicians working in this important specialty? If you answered "yes," then the American Board of Obesity Medicine (ABOM) Item Writing Committee is looking for you.
The ABOM Item Writing Committee oversees the creation of new items for the ABOM item bank of examination questions. Currently, the ABOM is seeking new Item Writing Committee members. Committee members are provided with annual item writing training in coordination with the National Board of Medical Examiners (NBME), the ABOM's test administration partner. To apply, complete the application form or contact ABOM at info@abom.org to learn more.
Please note: To maintain absolute confidentiality and separation between the examination writers and all preparatory or review courses for this examination, ABOM Item Writing committee members are not allowed to teach, lecture, provide seminars, assist, make comment or in any way participate in such courses while serving the Board.
Contributed by TOS Early Career Committee
Michael D. Jensen, MD, FTOS |
It's time for another edition of the Q&A interviews with TOS Fellows! This is the perfect opportunity to get to know leaders in the obesity field a little better and learn more about their personal lives outside of work. Here are some questions and answers from our interview with TOS Fellow Michael D. Jensen, MD, FTOS, Thomas J. Watson, Jr. Professor in Honor of Dr. Robert L. Frye at the Mayo College of Medicine, Rochester, MN.
Q: Will you tell us about your current work and your professional developmental trajectory?
A: My area of interest is in how fatty acid metabolism varies in different types of obesity and how this relates to overall energy metabolism insulin action. We conduct complex clinical physiology studies to understand how adipose tissue fatty acid metabolism relates to disease susceptibility at the level of muscle and liver. As with most clinical investigators, the professional trajectory is not as rapid as I would like, but the good news is that with enough experience it's easier to make sense out of a wide variety of obesity-related findings.
Q: What aspects of obesity research are the most exciting to you right now?
A: This is the best time for obesity research EVER! We know more, we can do more and can contribute more to improved human health.
Q: What advice do you have for today's junior obesity researchers?
A: It's hard now, it's been hard before, it will be hard again in the future — but times will come when it is easier to get funded and make progress. Hang in there.
Q: What are your favorite things to do when you're not at work?
A: Stay physically active, read for education and escape, and spend time with friends and family.
Read the rest of the interview with Dr. Jensen here. These interviews are featured bi-monthly in the TOS eNews. Don't miss the next one on Oct. 28!
Advertisement
TOS
Attention employers, recruiters and job seekers! TOS offers an opportunity to connect you with others exclusively in the obesity community through our online Job Center. Jobseekers can post an anonymous resume, search for listed jobs and create a personalized job alert. Recruiters can search for the best candidate and post jobs all at the click of a button. Check out the Job Center here.
HealthDay News
Studies have shown that women with larger hips tend to have a lower risk of Type 2 diabetes, and now scientists are getting a clearer picture of the genetics behind it all.
Recent research has shown that a variant in a gene called KLF14 is associated with the risk of developing Type 2 diabetes. It also seems to be a master regulator of how and where a woman’s body stores fat: Women with one particular "allele," or version, of the gene variant tend to have slimmer hips, while women with another are more "pear-shaped."
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
Medical News Today
Obesity is an ongoing health concern, affecting around 13 percent of people worldwide. Unless further government action is taken, the global obesity rate will rise another 4 percent by 2025, according to a new report from the World Obesity Federation. What is more, the report — released in line with the first World Obesity Day — reveals that 177 million adults across the globe will be severely obese and in need of treatment in the next 10 years unless more is done to combat the problem.
READ MORE
HealthCentral
What do you need in your weight loss toolkit in order to have better weight loss odds? Well, you need a diet that fits your goals and matches your daily life demands, you need to commit to regular exercise, and many experts recommend that you have a support group with whom you can share milestones or challenges. Now, a new study suggests that if you’re struggling with obesity, you can improve your weight loss if you have your doctor in your corner too.
READ MORE
UPI
Pregnant women with elevated blood sugar levels have an increased risk of giving birth to babies with congenital heart defects, researchers found in a new study.
During pregnancy, metabolic changes in women's bodies make glucose more available to the fetus than the mother, which can result in the development of gestational diabetes. Even when the mother's blood sugar levels are below those considered diabetic, however, the risk for defects increases, according to the study.
READ MORE
ConscienHealth
The notion of endorphins kicking in to produce a runner's high at the end of a good run is an enduring legend taken as an absolute truth by most runners. The catch is that no real evidence exists to prove that's how it works. But recently we've had a flurry of animal research suggesting that endocannabinoids and leptin — hormones involved in regulating hunger — may have more to do with a runner's high than endorphins.
READ MORE
Medgadget
Cardiovascular disease is a major cause of death in the U.S. and rest of the world. These diseases are primarily related with heart and blood vessels disorders, such as ischemic heart disease, dyslipidemia, stroke, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease and others. These disorders are mainly reported due to obesity, high cholesterol, smoking, excessive alcohol use and poor lifestyle.
READ MORE
Philadelphia Business Journal
Symmetry Therapeutics achieved its goal of raising $30,000 — with just $133 to spare — via a crowdfunding campaign to help fund the Philadelphia-based startup's research into new therapies to treat obesity.
The narrow margin by which the company hit its goal didn't bother co-founder and CEO Jon Brestoff Parker.
READ MORE
|
|
|
Advertisement
Advertisement
|
|
|
Advertisement
|
|
Advertisement
|
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
